Over the past decade, scientific as well as business needs have pushed the pharmaceutical industry to more closely align drug discovery and drug development, in order to more rapidly advance optimal preclinical drug candidates (PDCs). Towards this end, pharmaceutical scientists now routinely provide enabled formulations for key in vivo studies in discovery and work together with medicinal chemists to help identify and progress promising PDCs.This presentation gives a overview of some effective drug delivery tools Pharm R&D can bring to bear in Discovery space.  We also describe some examples where various partner groups from Merck Discovery and Development worked together to increase the speed of drug lead identification, optimization and the PDC approval process.

Survey of drug delivery strategies in discovery space

244th National Meeting (2012)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.